Ryman Healthcare Ltd. (NZ:RYM)
:RYM
Want to see NZ:RYM full AI Analyst Report?
Total Valuation
Ryman Healthcare has a market cap or net worth of $2.31B. The enterprise value is $3.82B.
Market Cap$2.31B
Enterprise Value$3.82B
Share Statistics
Ryman Healthcare has 1,015,729,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,015,729,060
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ryman Healthcare’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -1.06%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-1.06%
Return on Capital Employed (ROCE)-0.01
Revenue Per Employee92.70K
Profits Per Employee0.00
Employee Count7,700
Asset Turnover0.06
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ryman Healthcare is ―. Ryman Healthcare’s PEG ratio is 0.00049.
PE Ratio―
PS Ratio2.75
PB Ratio0.46
Price to Fair Value0.46
Price to FCF6.47
Price to Operating Cash Flow8.53
PEG Ratio0.00049
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 713.80M and earned -436.83M in profits. Earnings per share was -0.62.
Revenue713.80M
Gross Profit713.80M
Operating Income-118.26M
Pretax Income-215.39M
Net Income-436.83M
EBITDA-27.16M
Earnings Per Share (EPS)-0.62
Cash Flow
In the last 12 months, operating cash flow was 271.48M and capital expenditures -31.45M, giving a free cash flow of 240.03M billion.
Operating Cash Flow271.48M
Free Cash Flow240.03M
Free Cash Flow per Share0.24
Dividends & Yields
Ryman Healthcare pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.77
52-Week Price Change-1.81%
50-Day Moving Average2.32
200-Day Moving Average2.61
Relative Strength Index (RSI)36.13
Average Volume (3m)1.12M
Important Dates
Ryman Healthcare upcoming earnings date is May 26, 2026, TBA (Confirmed).
Last Earnings DateNov 26, 2025
Next Earnings DateMay 26, 2026
Ex-Dividend Date―
Financial Position
Ryman Healthcare as a current ratio of 0.24, with Debt / Equity ratio of 40.41%
Current Ratio0.24
Quick Ratio0.24
Debt to Market Cap0.86
Net Debt to EBITDA-61.78
Interest Coverage Ratio-0.85
Taxes
In the past 12 months, Ryman Healthcare has paid 221.44M in taxes.
Income Tax221.44M
Effective Tax Rate-1.03
Enterprise Valuation
Ryman Healthcare EV to EBITDA ratio is -133.96, with an EV/FCF ratio of 12.01.
EV to Sales5.10
EV to EBITDA-133.96
EV to Free Cash Flow12.01
EV to Operating Cash Flow8.87
Balance Sheet
Ryman Healthcare has $8.91M in cash and marketable securities with $1.67B in debt, giving a net cash position of -$1.66B billion.
Cash & Marketable Securities$8.91M
Total Debt$1.67B
Net Cash-$1.66B
Net Cash Per Share-$1.64
Tangible Book Value Per Share$5.98
Margins
Gross margin is -8.07%, with operating margin of -16.57%, and net profit margin of -61.20%.
Gross Margin-8.07%
Operating Margin-16.57%
Pretax Margin-30.18%
Net Profit Margin-61.20%
EBITDA Margin-3.80%
EBIT Margin-10.59%
Analyst Forecast
The average price target for Ryman Healthcare is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast12.30%
EPS Growth Forecast-569.58%